These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 35039246

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Diagnostic Performance of 99mTc-Sestamibi SPECT/CT and 18F-Choline PET/CT in Locating Hyperfunctioning Parathyroid Glands in Patients with Primary Hyperparathyroidism.
    Mandic A, Kraljevic I, Skoric Polovina T, Zibar Tomsic K, Dusek T, Balasko A, Solak M, Kastelan D.
    Exp Clin Endocrinol Diabetes; 2024 Apr; 132(4):216-220. PubMed ID: 38320618
    [Abstract] [Full Text] [Related]

  • 23. FCH-PET/CT in Primary Hyperparathyroidism With Discordant/Negative MIBI Scintigraphy and Ultrasonography.
    Koumakis E, Gauthé M, Martinino A, Sindayigaya R, Delbot T, Wartski M, Clerc J, Roux C, Borderie D, Cochand-Priollet B, Cormier C, Gaujoux S.
    J Clin Endocrinol Metab; 2023 Jul 14; 108(8):1958-1967. PubMed ID: 36750257
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. 11C-methionine PET/CT imaging of 99mTc-MIBI-SPECT/CT-negative patients with primary hyperparathyroidism and previous neck surgery.
    Traub-Weidinger T, Mayerhoefer ME, Koperek O, Mitterhauser M, Duan H, Karanikas G, Niederle B, Hoffmann M.
    J Clin Endocrinol Metab; 2014 Nov 14; 99(11):4199-205. PubMed ID: 25029418
    [Abstract] [Full Text] [Related]

  • 26. 18F-choline PET/CT for parathyroid scintigraphy: significantly lower radiation exposure of patients in comparison to conventional nuclear medicine imaging approaches.
    Rep S, Hocevar M, Vaupotic J, Zdesar U, Zaletel K, Lezaic L.
    J Radiol Prot; 2018 Mar 14; 38(1):343-356. PubMed ID: 29339573
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Upfront F18-choline PET/CT versus Tc99m-sestaMIBI SPECT/CT guided surgery in primary hyperparathyroidism: the randomized phase III diagnostic trial APACH2.
    Quak E, Lasne Cardon A, Ciappuccini R, Lasnon C, Bastit V, Le Henaff V, Lireux B, Foucras G, Jaudet C, Berchi C, Grellard JM, Lequesne J, Clarisse B, Bardet S.
    BMC Endocr Disord; 2021 Jan 07; 21(1):3. PubMed ID: 33413316
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Does 18F-Fluorocholine PET/CT add value to positive parathyroid scintigraphy in the presurgical assessment of primary hyperparathyroidism?
    Imperiale A, Bani J, Bottoni G, Latgé A, Heimburger C, Catrambone U, Vix M, Treglia G, Piccardo A.
    Front Med (Lausanne); 2023 Jan 07; 10():1148287. PubMed ID: 37181366
    [Abstract] [Full Text] [Related]

  • 31. Enabling minimal invasive parathyroidectomy for patients with primary hyperparathyroidism using Tc-99m-sestamibi SPECT-CT, ultrasound and first results of (18)F-fluorocholine PET-CT.
    Kluijfhout WP, Vorselaars WM, Vriens MR, Borel Rinkes IH, Valk GD, de Keizer B.
    Eur J Radiol; 2015 Sep 07; 84(9):1745-51. PubMed ID: 26047823
    [Abstract] [Full Text] [Related]

  • 32. Preoperative imaging in primary hyperparathyroidism: Are 11 C-Choline PET/CT and 99m Tc-MIBI/123 Iodide subtraction SPECT/CT interchangeable or do they supplement each other?
    Christensen JW, Ismail A, Søndergaard SB, Bennedbaek FN, Nygaard B, Jensen LT, Trolle W, Holst-Hahn C, Zerahn B, Kristensen B, Krakauer M.
    Clin Endocrinol (Oxf); 2022 Sep 07; 97(3):258-267. PubMed ID: 35150160
    [Abstract] [Full Text] [Related]

  • 33. F18-Choline PET/CT or MIBI SPECT/CT in the Surgical Management of Primary Hyperparathyroidism: A Diagnostic Randomized Clinical Trial.
    Quak E, Lasne-Cardon A, Cavarec M, Lireux B, Bastit V, Roudaut N, Salaun PY, Keromnes N, Potard G, Vaduva P, Esvant A, Jegoux F, de Crouy-Chanel O, Devillers A, Guery C, Lasnon C, Ciappuccini R, Legrand B, Estienne A, Christy F, Grellard JM, Bardet S, Clarisse B.
    JAMA Otolaryngol Head Neck Surg; 2024 Aug 01; 150(8):658-665. PubMed ID: 38900416
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The EANM practice guidelines for parathyroid imaging.
    Petranović Ovčariček P, Giovanella L, Carrió Gasset I, Hindié E, Huellner MW, Luster M, Piccardo A, Weber T, Talbot JN, Verburg FA.
    Eur J Nucl Med Mol Imaging; 2021 Aug 01; 48(9):2801-2822. PubMed ID: 33839893
    [Abstract] [Full Text] [Related]

  • 38. Will 18F-fluorocholine PET/CT replace other methods of preoperative parathyroid imaging?
    Giovanella L, Bacigalupo L, Treglia G, Piccardo A.
    Endocrine; 2021 Feb 01; 71(2):285-297. PubMed ID: 32892309
    [Abstract] [Full Text] [Related]

  • 39. Application value of contrast-enhanced ultrasound in preoperative localization of microwave ablation for primary hyperparathyroidism.
    Liu F, Zang L, Li Y, Guan Z, Liu Y, Yu X, Han Z, Liang P.
    J Appl Clin Med Phys; 2022 Dec 01; 23(12):e13802. PubMed ID: 36250922
    [Abstract] [Full Text] [Related]

  • 40. Diagnostic value of clinical parameters and parathyroid scintigraphy for asymptomatic primary hyperparathyroidism.
    Ning Y, Chen D, Huang Z, Lou C.
    Hell J Nucl Med; 2020 Dec 01; 23(2):148-157. PubMed ID: 32716406
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.